In pediatric B‐ALL, the AIEOP‐BFM group defined IKZF1plus as IKZF1 deletions combined with CDKN2A, CDKN2B, PAX5, or PAR1 deletions without an ERG deletion, which confers the worst outcomes.8 Here, IKZF1 is linked to acute lymphoblastic leukemia.